This country profile provides an overview of Egypt’s progress in reaching those in need of mass NTD treatment based on 2017 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Download country profile

Treatment coverage

Elephantiasis
100%
Blinding trachoma
0%
Intestinal worms
N/A
Bilharzia
95%
River blindness
N/A
4.95 million people received treatment in Egypt in 2017 0.07 million people did not receive treatment in in Egypt in 2017

Elephantiasis

Egypt does not require mass treatment for elephantiasis.

Blinding trachoma

Treatment coverage was 0% in 2016 and 2017.

People needing treatment
1.74m
People receiving treatment
0m

Intestinal worms

Egypt does not require mass treatment for intestinal worms.

Bilharzia

Treatment coverage decreased from 100% in 2016 to 95% in 2017.

School-aged children needing treatment
2.93m
School-aged children receiving treatment
2.77m

River blindness

Egypt does not require mass treatment for river blindness.